Short term, relative effectiveness of four doses versus three doses of BNT162b2 vaccine in people aged 60 years and older in Israel: retrospective, test negative, case-control study.

Gazit, Sivan; Saciuk, Yaki; Perez, Galit; Peretz, Asaf; Pitzer, Virginia E; Patalon, Tal

Gazit, Sivan; Saciuk, Yaki; Perez, Galit; Peretz, Asaf; Pitzer, Virginia E; Patalon, Tal.

Afiliação

Gazit S; Kahn Sagol Maccabi Research and Innovation Centre, Maccabi Healthcare Services, Tel Aviv, Israel gazit_s@mac.org.il.
Saciuk Y; Maccabitech Institute for Research and Innovation, Maccabi Healthcare Services, Tel Aviv, Israel.
Perez G; Kahn Sagol Maccabi Research and Innovation Centre, Maccabi Healthcare Services, Tel Aviv, Israel.
Peretz A; Maccabitech Institute for Research and Innovation, Maccabi Healthcare Services, Tel Aviv, Israel.
Pitzer VE; Kahn Sagol Maccabi Research and Innovation Centre, Maccabi Healthcare Services, Tel Aviv, Israel.
Patalon T; Department of Epidemiology of Microbial Diseases and Public Health Modeling Unit, Yale School of Public Health, Yale University, New Haven, CT, USA.

BMJ ; 377: e071113, 2022 05 24.

Article em En | MEDLINE | ID: mdl-35609888

Assuntos

Vacinas contra COVID-19; COVID-19; Idoso; Vacina BNT162; COVID-19/epidemiologia; COVID-19/prevenção & controle; Estudos de Casos e Controles; Humanos; Israel/epidemiologia; Pessoa de Meia-Idade; Estudos Retrospectivos; SARS-CoV-2

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Aged / Humans / Middle aged País/Região como assunto: Asia Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google